Celltein LLC:1287371 - scale up synthesis of three synthetic intermediates.

Ended Purchase Order Awarded Last action

Contract number
75N95019P00221
Awardee
Awarding agency
Obligated
$24,820

Award facts

Opportunity
Contract value 100% obligated
$24,820.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
Total Small Business
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Somerset, Franklin Township, NJ 08873, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$1,780
Original award $26,600

Quick answers

Who was awarded contract 75N95019P00221?

75N95019P00221 was awarded to Celltein LLC by National Institute on Drug Abuse (National Institutes of Health) on March 27, 2019.

How much is contract 75N95019P00221 worth?

The government has obligated $24,820 on 75N95019P00221.

Which agency awarded contract 75N95019P00221?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019P00221, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95019P00221 competed?

The extent of competition for 75N95019P00221 was competed under sap. The government received 4 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award